GaryPFrenetteMD

Oncology • Charlotte, NC

Hematologic Oncology

Associate Clinical Professor of Medicine, University of North Carolina School of Medicine

Join to view full profile

Dr. Frenette is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Frenette's full profile

Already have an account?

Office
1000 Blythe Blvd
Charlotte, NC 28203
Phone(704) 355-2000
Fax(704) 355-5800
Is this information wrong?

Education & Training

Washington University - Barnes-Jewish HospitalFellowship, Hematology/Oncology, 1992 - 1996
Duke University HospitalResidency, Internal Medicine, 1990 - 1992
University of Michigan Medical SchoolClass of 1990

Certifications & Licensure

NC State Medical License 1996 - 2021
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Charlotte Magazine Castle Connolly, 2005
Most Compassionate Doctor American Registry
Top MD Consumers Checkbook

Clinical Trials

A Pilot Study Testing Single-Agent Regorafenib in Advanced Previously-Treated Adenocarcinoma of the Pancreas Start of enrollment: 2014 Jun 01Kim, E.,Schwartz, G.,Brouse, G.,Salmon, J.S.,Hellner, L.,West, N.,Elliott, R.,Nazemzadeh, R.
Assessment of Overall Survival of FOLFOX6m Plus SIR-Spheres Microspheres Versus FOLFOX6m Alone as First-line Treatment in Patients With Non-resectable Liver Metastases From Primary Colorectal Carcinoma in a Randomised Clinical Study Start of enrollment: 2013 Feb 01Yi-Jen Chen, MD, Sajeve Thomas, MD, Pablo Ferraro, MD, James Bui, MD, Francis Facchini, MD, Dr. David Kirsch, Navesh Sharma, DO, Andreas Kaubisch, MD, Renuka Iyer, MD, Patrick Boland, MD, Dr. Mark Westcot...

Publications & Presentations

PubMed

Sequential therapy for the locally advanced larynx and hypopharynx cancer subgroup in TAX 324: survival, surgery, and organ preservation
Marshall R. Posner, Charles M. Norris, Lori J. Wirth, Dong M. Shin, Kevin J. Cullen, Eric Winquist, Cesar R. Blajman, E. A. Mickiewicz, G. P. Frenette, L. F. Plinar, R...> ;Annals of Oncology. 2009 May 1
Double-Blind Randomized Phase II Study of the Combination of Sorafenib and Dacarbazine in Patients With Advanced Melanoma : A Report From the 11715 Study Group
David F. McDermott, Jeffrey A. Sosman, Rene Gonzalez, F. Stephen Hodi, Gerald P. Linette, Jon M. Richards, James W. Jakub, Muralidhar Beeram, Stefano R. Tarantolo, San...> ;Journal of Clinical Oncology. 2008 May 1
A phase II study of milataxel: a novel taxane analogue in previously treated patients with advanced colorectal cancer
Ramesh K. Ramanathan, Joel Picus, Haralambos Raftopoulos, Stephen A. Bernard, A. Craig Lockhart, Gary Frenette, John S. Macdonald, Susan A. Melin, Daniel J. Berg, Fran...> ;Cancer Chemotherapy and Pharmacology. 2008 Mar 1
Phase 2 trial of talabostat and cisplatin in patients with stage IV melanoma.
Cunningham C, Pavlick AC, Khan KD, Frenette G, O'Day S, Stephenson J, Gonzalez R, Yang Z, Vrhovac V, Uprichard MJ> ;J. Clin. Oncol.. 2006-06-20
Gene expression changes in buccal mucosa tissue 2 days post-chemotherapy in acute myelogenous leukemia (AML) patients.
Brennan MT, Kent ML, Mostafavi Z, Frenette GP, Fox PC, Lockhart PB> ;J. Clin. Oncol.. 2005-06-01
Phase 2 study of talabostat and cisplatin in stage IV melanoma.
Uprichard MJ, O'Day SJ, Pavlick AC, Richards DA, Frenette G, Stephenson J, Anthony S, Pacciucci PA, Vrhovac V, Cunningham C> ;J. Clin. Oncol.. 2005-06-01
Randomized controlled trial of pilocarpine hydrochloride for the moderation of oral mucositis during autologous blood stem cell transplantation.
Lockhart PB, Brennan MT, Kent ML, Packman CH, Norton HJ, Fox PC, Frenette G> ;Bone Marrow Transplant.. 2005-04-01
Multicenter Phase I-II Trial of Docetaxel, Cisplatin, and Fluorouracil Induction Chemotherapy for Patients With Locally Advanced Squamous Cell Cancer of the Head and Neck
Marshall R. Posner, Bonnie S. Glisson, G. Frenette, M. Al-Sarraf, A. D. Colevas, C. M. Norris, J. D. Seroskie, Donghoon Shin, R. Olivares, C. A. Garay> ;Journal of Clinical Oncology. 2001 Feb 15
Biosynthesis and deposition of a noncovalent laminin-heparan sulfate proteoglycan complex and other basal lamina components by a human malignant cell line.
Gary P. Frenette, Raymond W. Ruddon, R F Krzesicki, J A Naser, Barry P. Peters> ;Journal of Biological Chemistry. 1989 Feb 25
Molecular methodology to assess the impact of cancer chemotherapy on the oral bacterial flora: a pilot study.
Napeñas, J. J., Brennan, M. T., Coleman, S., Kent, M. L., Noll, J., Frenette, G., Nussbaum, M. L., Mougeot, J. L., Paster, B. J., Lockhart, P. B., Bahrani-Mougeot, F. K.> ;Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 Apr
Phase II assessment of talabostat and cisplatin in second-line stage IV melanoma.
Eager, R. M., Cunningham, C. C., Senzer, N. N., Stephenson, J., Anthony, S. P., O'Day, S. J., Frenette, G., Pavlick, A. C., Jones, B., Uprichard, M., Nemunaitis, J.> ;BMC Cancer. 2009 Aug 01
Phase II Trial of docetaxel and cisplatin combination chemotherapy in patients with squamous cell carcinoma of the head and neck.
Glisson, B. S., Murphy, B. A., Frenette, G., Khuri, F. R., Forastiere, A. A.> ;J Clin Oncol. 2002 Mar 15
Join now to see all

Hospital Affiliations

Atrium Health's Carolinas Medical CenterCharlotte, North Carolina
Atrium Health UnionMonroe, North Carolina
Atrium Health PinevilleCharlotte, North Carolina
University of North Carolina HospitalsChapel Hill, North Carolina
Atrium Health University CityCharlotte, North Carolina